Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

Experimental Neurology
Corinne G JolivaltE Masliah

Abstract

A number of studies suggest an association between Alzheimer's disease (AD) and diabetes: AD patients show impaired insulin function, whereas cognitive deficits and increased risk of developing AD occur in diabetic patients. The reasons for the increased risk are not known. Recent studies of disturbances in the insulin-signaling pathway have revealed new perspectives on the links between AD and Type 1 diabetes with a particular focus on glycogen synthase-kinase-3 (GSK3). We have therefore characterized a mouse model of combined insulin-deficient diabetes and AD and find that diabetes exaggerated defects in the brain of APP transgenic mice. Mice with combined APP overexpression and diabetes showed a decreased insulin receptor activity and an increased GSK3beta activity. Concomitantly, tau phosphorylation and number of Abeta plaques, the two pathologic hallmarks of AD, were increased in the brain of diabetic-APP transgenic mice. Our results indicate that the pathologic features of AD are exaggerated in the brain of APP transgenic mice that have concurrent insulin-deficient diabetes, and underscore a possible mechanism of brain dysfunction common to AD and diabetes.

References

Feb 1, 1979·Journal of Comparative and Physiological Psychology·C A Barnes
Nov 1, 1996·Diabetologia·A OttM M Breteler
Nov 5, 1997·Annals of the New York Academy of Sciences·C L LeibsonP J Palumbo
Jun 27, 2002·Trends in Pharmacological Sciences·Laura GaspariniHuaxi Xu
May 23, 2003·Nature·Christopher J PhielPeter S Klein
Oct 15, 2003·The Journal of Cell Biology·Ming-Sum LeeLi-Huei Tsai
Apr 20, 2004·European Journal of Pharmacology·Wei-Qin ZhaoDaniel L Alkon
Apr 23, 2004·Trends in Biochemical Sciences·Richard S Jope, Gail V W Johnson
May 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Wendy NobleKaren Duff
Jan 20, 2007·Genes, Brain, and Behavior·R S ReisererM P McDonald
Apr 26, 2007·Diabetes·Zhen-guo LiAnders A F Sima
Sep 12, 2007·Neurology·J M BurnsW M Brooks
Jan 22, 2008·Lancet Neurology·Geert Jan BiesselsChristopher M Ryan

❮ Previous
Next ❯

Citations

May 4, 2011·Cellular and Molecular Neurobiology·Kyle C WilcoxWilliam L Klein
Jun 27, 2012·Cellular and Molecular Neurobiology·Zhi-Gang YaoChuan Qin
Sep 11, 2012·Neuroscience Bulletin·Xiao-Jing SunChun-Jiu Zhong
Feb 19, 2013·Ageing Research Reviews·Jim R FadelLawrence P Reagan
Sep 16, 2010·Nature Reviews. Neurology·Catrina Sims-RobinsonEva L Feldman
Oct 18, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jason PittWilliam L Klein
Apr 26, 2014·Disease Models & Mechanisms·Nicholas J AndersonCorinne G Jolivalt
Sep 3, 2013·Molecular Neurobiology·Yanxing ChenCheng-Xin Gong
Aug 7, 2013·Pharmacology & Therapeutics·Margaret K KingEléonore Beurel
Nov 12, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Magdalena Labieniec-WatalaCezary Watala
Mar 13, 2016·Neuroscience and Biobehavioral Reviews·David Baglietto-VargasFrank M LaFerla
Jun 14, 2015·Journal of Neural Transmission·Ting-Ting YangChu-Wan Lee
Apr 9, 2016·International Journal of Molecular Sciences·Nobuyuki Kimura
Apr 17, 2016·Neurochemical Research·Patrícia NardinCarlos-Alberto Gonçalves
Jul 15, 2015·Molecular Neurobiology·Juan José Ramos-RodriguezMónica Garcia-Alloza
Apr 19, 2015·Journal of Neuroinflammation·Amir NazemYousef Al-Abed
Dec 3, 2013·Pharmacology, Biochemistry, and Behavior·Yao-Wu LiuXiao-Xing Yin
Apr 20, 2017·International Journal of Molecular Sciences·Miaoyan ZhengHuan Liu
May 14, 2016·Brain Research·Wilma Helena OliveiraChristina Alves Peixoto
Jul 16, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Mark W AlbersLi I Zhang
Dec 19, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Tongrong HeZvonimir S Katusic
Jan 19, 2019·The Journal of Clinical Endocrinology and Metabolism·Anna ShalimovaKrzysztof Narkiewicz
Jun 4, 2019·Journal of Alzheimer's Disease : JAD·Vineeth ThirunavuBrian A Gordon
Feb 3, 2011·British Journal of Clinical Pharmacology·Kawser AkterRobert B Raffa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.